Mesoblast Ltd - ADR

Mesoblast Ltd - ADR

MESO

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.96B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mesoblast Ltd - ADRMesoblast Ltd - ADR-33.8--10%-0.2
$39.00

Target Price by Analysts

145% upsideMesoblast Target Price DetailsTarget Price
$-4.94

Current Fair Value

131% downside

Overvalued by 131% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.96 Billion
Enterprise Value$1.99 Billion
Dividend Yield$- (-)
Earnings per Share$-0.45
Beta0.81
Outstanding Shares129,775,449

Return

Return on Equity-10.12%ROE
Return on Assets-7.44%
Return on Invested Capital-7.41%

Valuation & Multiples

P/E Ratio-33.84P/E Ratio
PEG49.76PEG
Price to Sales-Price to Sales
Price to Book Ratio3.98Price to Book Ratio
Enterprise Value to Revenue16.52
Enterprise Value to EBIT-38.77
Enterprise Value to Net Income-35
Total Debt to Enterprise0.06
Debt to Equity0.22Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 4, 2026
EPS Estimate
$-0.11
Average shareholder expectation
Revenue Estimate
$47.13 M
Average shareholder expectation

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
$-0.15
Average shareholder expectation
Revenue Estimate
$87.89 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0935 1.92%
Total Calls2,322,500 67.80%
Total Puts217,100 39.26%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.99% 0.46%
Total Invested$53.30M 5.46%
Investors Holding78 3.00%

ESG Score

No data

About Mesoblast Ltd

CEO: Silviu Itescu